Cargando…
Lactobacillus paracasei Reduces Intestinal Inflammation in Adoptive Transfer Mouse Model of Experimental Colitis
Studies showed that specific probiotics provide therapeutic benefits in inflammatory bowel disease. In vitro evidence suggested that Lactobacillus paracasei also called ST11 (CNCM I-2116) is a potent strain with immune modulation properties. However, little is known about its capacity to alleviate i...
Autores principales: | Oliveira, Manuel, Bosco, Nabil, Perruisseau, Genevieve, Nicolas, Jeanne, Segura-Roggero, Iris, Duboux, Stéphane, Briand, Muriel, Blum, Stéphanie, Benyacoub, Jalil |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3145352/ https://www.ncbi.nlm.nih.gov/pubmed/21808650 http://dx.doi.org/10.1155/2011/807483 |
Ejemplares similares
-
Engineered Lactobacillus paracasei Producing Palmitoylethanolamide (PEA) Prevents Colitis in Mice
por: Esposito, Giuseppe, et al.
Publicado: (2021) -
Therapeutic effects of Lactobacillus paracasei subsp. paracasei NTU 101 powder on dextran sulfate sodium-induced colitis in mice
por: Chen, Chien-Li, et al.
Publicado: (2018) -
A Palmitoylethanolamide Producing Lactobacillus paracasei Improves Clostridium difficile Toxin A-Induced Colitis
por: Esposito, Giuseppe, et al.
Publicado: (2021) -
Coculture Strategy for Developing Lactobacillus paracasei PS23 Fermented Milk with Anti-Colitis Effect
por: Lee, Kai-Yi, et al.
Publicado: (2021) -
Lactobacillus paracasei feeding improves immune control of influenza infection in mice
por: Belkacem, Nouria, et al.
Publicado: (2017)